HeartBeam, Inc. (BEAT)
- Previous Close
1.8400 - Open
1.9000 - Bid 1.3800 x 200
- Ask 2.3100 x 200
- Day's Range
1.8000 - 1.9000 - 52 Week Range
1.4500 - 3.4800 - Volume
39,680 - Avg. Volume
76,081 - Market Cap (intraday)
62.527M - Beta (5Y Monthly) -0.58
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7300 - Earnings Date May 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.00
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
www.heartbeam.com21
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BEAT
View More
Performance Overview: BEAT
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BEAT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BEAT
View MoreValuation Measures
Market Cap
62.05M
Enterprise Value
59.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
37.52
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-121.82%
Return on Equity (ttm)
-221.11%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-19.45M
Diluted EPS (ttm)
-0.7300
Balance Sheet and Cash Flow
Total Cash (mrq)
2.38M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-7.65M